Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

被引:515
作者
Naito, A
Azuma, S
Tanaka, S
Miyazaki, T
Takaki, S
Takatsu, K
Nakao, K
Nakamura, K
Katsuki, M
Yamamoto, T
Inoue, J
机构
[1] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 1130033, Japan
[3] Univ Tokyo, Inst Med Sci, Div DNA Biol & Embryo Engn, Dept Immunol,Ctr Expt Med,Minato Ku, Tokyo 1088639, Japan
关键词
D O I
10.1046/j.1365-2443.1999.00265.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: TRAF6, a member of the tumour necrosis factor receptor-associated factor family, was first identified as a transducer of CD40 and interleukin-l receptor (IL-1R) signals based on the interaction of TRAF6 with the cytoplasmic tail of CD40 and with the IL-1R associated kinase in vitro. However, the functions of TRAF6 in vivo remain unidentified. Results: We show that TRAF6(-/-) mice exhibit severe osteopetrosis and are defective in osteoclast formation. In vitro culture experiments revealed that osteoclast precursor cells derived from TRAF6(-/-) mice are unable to differentiate to functional osteoclasts in response to osteoclast differentiation factor (ODF), In bone marrow of TRAF6(-/-) mice, the number of sIgM(+)B220(+) immature B cells is markedly reduced while the ratio of proB to preB cells is not affected. In contrast, development of thymocytes is not affected. Furthermore, TRAF6(-/-) mice are defective in lymph node organogenesis and IL-1 signalling in thymocytes. Conclusions: The results identify TRAF6 as an essential component of ODF signalling pathway, and also show that TRAF6 plays pivotal roles in immune and inflammatory systems in vivo.
引用
收藏
页码:353 / 362
页数:10
相关论文
共 43 条
[31]   A NOVEL FAMILY OF PUTATIVE SIGNAL TRANSDUCERS ASSOCIATED WITH THE CYTOPLASMIC DOMAIN OF THE 75 KDA TUMOR-NECROSIS-FACTOR RECEPTOR [J].
ROTHE, M ;
WONG, SC ;
HENZEL, WJ ;
GOEDDEL, DV .
CELL, 1994, 78 (04) :681-692
[32]   A NOVEL MEMBER OF THE TRAF FAMILY OF PUTATIVE SIGNAL-TRANSDUCING PROTEINS BINDS TO THE CYTOSOLIC DOMAIN OF CD40 [J].
SATO, T ;
IRIE, S ;
REED, JC .
FEBS LETTERS, 1995, 358 (02) :113-118
[33]   TARGETED DISRUPTION OF THE C-SRC PROTOONCOGENE LEADS TO OSTEOPETROSIS IN MICE [J].
SORIANO, P ;
MONTGOMERY, C ;
GESKE, R ;
BRADLEY, A .
CELL, 1991, 64 (04) :693-702
[34]   DIRECT EFFECTS OF 17-BETA-ESTRADIOL ON TRABECULAR BONE IN OVARIECTOMIZED RATS [J].
TAKANOYAMAMOTO, T ;
RODAN, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2172-2176
[35]   Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 [J].
Tondravi, MM ;
McKercher, SR ;
Anderson, K ;
Erdmann, JM ;
Quiroz, M ;
Maki, R ;
Teitelbaum, SL .
NATURE, 1997, 386 (6620) :81-84
[36]   Two differently regulated nuclear factor κB activation pathways triggered by the cytoplasmic tail of CD40 [J].
Tsukamoto, N ;
Kobayashi, N ;
Azuma, S ;
Yamamoto, T ;
Inoue, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) :1234-1239
[37]   HEMATOLOGICAL CHARACTERIZATION OF CONGENITAL OSTEOPETROSIS IN OP OP MOUSE - POSSIBLE MECHANISM FOR ABNORMAL MACROPHAGE DIFFERENTIATION [J].
WIKTORJEDRZEJCZAK, W ;
AHMED, A ;
SZCZYLIK, C ;
SKELLY, RR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (05) :1516-1527
[38]   The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor [J].
Wong, BR ;
Josien, R ;
Lee, SY ;
Vologodskaia, M ;
Steinman, RM ;
Choi, YW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28355-28359
[39]   TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor [J].
Wong, BR ;
Josien, R ;
Lee, SY ;
Sauter, B ;
Li, HL ;
Steinman, RM ;
Choi, YW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (12) :2075-2080
[40]   Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses [J].
Xu, Y ;
Cheng, GH ;
Baltimore, D .
IMMUNITY, 1996, 5 (05) :407-415